- Home
- ZLAB vs BUR Comparison
ZLAB vs BUR Comparison
Compare ZLAB & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- BUR
- Stock Information
- Founded
- ZLAB 2013
- BUR 2009
- Country
- ZLAB China
- BUR Guernsey
- Employees
- ZLAB N/A
- BUR N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- BUR Finance: Consumer Services
- Sector
- ZLAB Health Care
- BUR Finance
- Exchange
- ZLAB Nasdaq
- BUR Nasdaq
- Market Cap
- ZLAB 3.6B
- BUR 2.9B
- IPO Year
- ZLAB 2017
- BUR 2010
- Fundamental
- Price
- ZLAB $32.54
- BUR $14.24
- Analyst Decision
- ZLAB Buy
- BUR Strong Buy
- Analyst Count
- ZLAB 5
- BUR 3
- Target Price
- ZLAB $54.28
- BUR $18.00
- AVG Volume (30 Days)
- ZLAB 782.4K
- BUR 3.2M
- Earning Date
- ZLAB 08-05-2025
- BUR 08-07-2025
- Dividend Yield
- ZLAB N/A
- BUR 0.86%
- EPS Growth
- ZLAB N/A
- BUR N/A
- EPS
- ZLAB N/A
- BUR 0.93
- Revenue
- ZLAB $418,326,000.00
- BUR $626,769,000.00
- Revenue This Year
- ZLAB $44.07
- BUR $32.22
- Revenue Next Year
- ZLAB $49.13
- BUR $6.31
- P/E Ratio
- ZLAB N/A
- BUR $15.20
- Revenue Growth
- ZLAB 43.72
- BUR N/A
- 52 Week Low
- ZLAB $16.01
- BUR $10.70
- 52 Week High
- ZLAB $44.34
- BUR $15.73
- Technical
- Relative Strength Index (RSI)
- ZLAB 40.19
- BUR 59.16
- Support Level
- ZLAB $34.26
- BUR $12.75
- Resistance Level
- ZLAB $35.72
- BUR $15.10
- Average True Range (ATR)
- ZLAB 1.12
- BUR 0.64
- MACD
- ZLAB -0.54
- BUR 0.29
- Stochastic Oscillator
- ZLAB 3.83
- BUR 79.01
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About BUR Burford Capital Limited
Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.